6WILSON J S,PODRID P J.Side effects from amiodarone[J].Am Heart J,1991,121(1):158-171.
7MALIK M,CAMM A J.Amiodarone after myocardial infarction:EMIAT and CAMIAT trials.Lancet[J].1997,349(9067):1767-1768.
8REMME W J,KRUYSSEN H A,LOOK M P,et al.Hemodynamic effects and tolerability of intravenous amiodarone in patients with impaired left ventricular function[J].Am Heart J,1991,122(1 Pt 1):96-103.
5Hassapoyannes CA,MclLaurin BT,Homung CA,et al.Normokinesia adjacent to left ventficular aneurysrn:a differential risk for sudden cardiac death.Eur J Hean Fail,2002,4(1):33-35.
6Epstein AE,Hallstrom AP,Rogers WJ,et al.Mortality following ventricular arrhythmia suppression by eneainide,flecainide,and morieifine after myocardial infarction.The original design concept of the Cardiac Arrhythmia Suppression Trial(CAST).JAMA,2003,270(20):2451-2455.
7胡大一,郭继鸿.中华心律学.北京:人民卫生出版社,2008:188-193.
8St J,Sutton M,Lee D,et al.Left ventricular remodeling and Yentricular arrhythmias after myocardial infarction.Circulation,2003,107(20):2577.
9Vrtovec B,Okrajsek R,Golicnik A,et al. Statins shorten. QTc in-terval without affecting plasma BNP leves in patients with advancedheart failure. J Heart Lung Transplant,2005 ,24 ( 2) :68-69.
10Wadhani N,Sarma J S,Singh B N,et al. Dose-dependent effects oforal dronedarone on the circadian variation of RR and QT intervalsin healthy subjects : implications for antiarrhythmic actions. J Card-iovasc Pharmacol Ther,2006,11(3) : 184-190.
